組織庫市場規模、佔有率和成長分析（按應用、最終用途和地區分類）－2026-2033年產業預測

預計到 2024 年，全球組織庫市場規模將達到 45.3 億美元，到 2025 年將達到 47.7 億美元，到 2033 年將達到 72.1 億美元，預測期（2026-2033 年）的複合年成長率為 5.3%。

由於心血管疾病、糖尿病和癌症等慢性疾病的日益普遍，以及創傷和嚴重燒燙傷病例的增加導致移植手術數量激增，全球組織庫市場正經歷顯著成長。這種需求的激增推動了對心臟瓣膜、角膜、皮膚移植片和骨碎片等重要人體組織供應的進一步需求，促使醫療機構和政府對組織庫基礎設施進行大規模投資。冷凍保存和玻璃化冷凍等保存技術的進步提高了保存組織的活性和安全性，降低了污染和劣化的風險，並延長了其保存期限。因此，醫療機構更願意在複雜的手術中使用保存的組織，從而改善患者的治療效果，並擴大組織庫在全球的應用。

全球組織庫市場按應用程式、組織庫類型、最終用途和地區進行細分。依應用分類，可分為再生醫學、藥物研發、組織工程及移植。依組織庫類型分類，可分為細胞庫、器官庫、組織庫三個部分。依最終用途分類，可分為醫院、研究機構和製藥公司。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球組織庫市場促進因素

人們對再生醫學日益成長的興趣正在推動全球組織庫市場的擴張。隨著幹細胞療法、組織移植和個人化醫療需求的不斷成長，組織庫已成為供應關鍵生物材料的重要管道。這種不斷成長的需求促進了組織保存技術的進步和全球生物銀行基礎設施的建設。因此，組織庫產業預計將迎來顯著成長，在滿足研究人員和醫療專業人員需求的同時，也為依賴高品質生物樣本的創新醫療解決方案的發展做出貢獻。

全球組織庫市場面臨的限制因素

全球組織庫市場的發展面臨許多挑戰，其中涉及組織捐贈、知情同意流程和隱私問題等倫理和法律的考量尤其突出。各國嚴格的監管規定和法律體制的差異進一步加劇了這些複雜性，使得組織庫難以確保營運實務的一致性。此外，不同地區不同的倫理標準也增加了組織採集和使用的複雜性，最終阻礙了組織庫在市場中有效運作和拓展服務的能力。

全球組織庫市場趨勢

全球組織庫市場正呈現日益顯著的趨勢，即擴大採用自動化生物銀行系統。這些系統顯著提高了組織採集、儲存和分析的操作效率和準確性。透過最大限度地減少人為錯誤並最佳化檢體保存，這些先進技術正在推動生物銀行流程的創新發展。這種轉變不僅提高了營運效率，也滿足了科學研究和臨床應用對高品質生物檢體日益成長的需求。因此，自動化技術的整合正成為組織庫發展的關鍵要素，促進了相關技術的進步，從而滿足醫療保健領域的研究和商業性需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 顧客購買行為分析

全球組織庫市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
• 冷凍保存裝置
• 解凍裝置
• 品管設備
• 其他

全球組織庫市場規模（依組織類型分類）及複合年成長率（2026-2033 年）

• 心臟瓣膜
• 角膜
• 腦和脊髓
• 骨骼和皮膚

全球組織庫市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 治療
• 化妝品
• 研究與開發
• 藥物發現

全球組織庫市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 生物樣本庫
• 醫院和診所
• 研究和學術機構
• 其他

全球組織庫市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Sigma-Aldrich Co.（US）
• BioLifeSolutions（US）
• Core dynamics GmbH（US）
• Taylor-Wharton（US）
• Panasonic Holdings Corporation（Japan）
• QIAGEN（Germany）
• VWR International, LLC（US）
• Danaher（US）
• Tecan Trading AG（Switzerland）
• Brooks Automation, Inc.（US）

結論與建議

Global Tissue Banking Market size was valued at USD 4.53 Billion in 2024 poised to grow from USD 4.77 Billion in 2025 to USD 7.21 Billion by 2033, growing at a CAGR of 5.3% in the forecast period (2026-2033).

The global tissue banking market is experiencing substantial growth due to the rising prevalence of chronic diseases, such as cardiovascular issues, diabetes, and cancer, along with increased cases of trauma and severe burns, which have led to more transplant surgeries. This surge necessitates a greater supply of essential human tissues, including heart valves, corneas, skin grafts, and bone segments, prompting significant investments from healthcare institutions and governments in tissue banking infrastructure. Advances in preservation techniques like cryopreservation and vitrification enhance the viability and safety of stored tissues, mitigating contamination and degradation risks while extending shelf life. Consequently, healthcare providers are more inclined to use banked tissues in complex procedures, leading to improved patient outcomes and broadening the applications of tissue banks worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Banking Market Segments Analysis

The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.

Driver of the Global Tissue Banking Market

The increasing interest in regenerative medicine plays a crucial role in the expansion of the global tissue banking market. As the necessity for stem cell therapies, tissue transplants, and customized medical treatments rises, tissue banks become essential in supplying vital biological materials. This heightened demand catalyzes advancements in tissue preservation technologies and the development of biobanking infrastructure on a worldwide scale. As a result, the tissue banking sector is poised for significant growth, addressing the needs of researchers and healthcare professionals while contributing to the advancement of innovative medical solutions that rely on quality biological samples.

Restraints in the Global Tissue Banking Market

The growth of the global tissue banking market faces significant challenges due to ethical and legal concerns related to tissue donation, consent processes, and privacy issues. These complexities are exacerbated by strict regulations and the diverse legal frameworks that exist in different countries, making it difficult for tissue banks to ensure consistent operational practices. Furthermore, the need to comply with varying local ethical standards adds layers of complexity to tissue collection and utilization, which ultimately hampers the ability of tissue banks to operate efficiently and expand their services within the marketplace.

Market Trends of the Global Tissue Banking Market

The global tissue banking market is experiencing a notable trend towards the increased adoption of automated biobanking systems, which significantly enhance the operational efficiency and accuracy of tissue collection, storage, and analysis. By minimizing human error and optimizing sample preservation, these advanced technologies are facilitating innovative approaches in biobanking processes. This shift not only streamlines operations but also aligns with the growing demand for high-quality biological samples in research and clinical applications. Consequently, the integration of automation is becoming a pivotal factor in the evolution of tissue banking, fostering advancements that cater to both scientific and commercial needs in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Customer Buying Behavior Analysis

Global Tissue Banking Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
• Cryopreservation Equipment
• Thawing Equipment
• Quality Control Equipment
• Others

Global Tissue Banking Market Size by Tissue Type & CAGR (2026-2033)

• Market Overview
• Heart Valves
• Cornea
• Brain and Spinal Cord
• Bone and Skin

Global Tissue Banking Market Size by Application & CAGR (2026-2033)

• Market Overview
• Therapeutic
• Cosmetic
• Research and Development
• Drug Discovery

Global Tissue Banking Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Biobanks
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Global Tissue Banking Market Size & CAGR (2026-2033)

• North America (Product, Tissue Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Tissue Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Tissue Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Tissue Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Tissue Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Co. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLifeSolutions (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Core dynamics GmbH (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taylor-Wharton (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panasonic Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VWR International, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Automation, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations